Two more biotechs, Marea and North Immunology, do reverse mergers
The reverse merger party is still buzzing. This time, it's a cardio and endocrine startup with two drugs in Phase 2 and a biotech working on a long-acting immunology and inflammation (I&I) drug. Mid-stage Marea ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- North Immunology joins biotech reverse merger boom with Aethlon deal biopharmadive.com
